NCT06858475Completed
Long-term Observation Of Patient Engagement in Automated Insulin Delivery
Source: ClinicalTrials.gov · Last updated 20 Jun 2025
Brief summary (registry, in English)
The purpose of this study is to assess the long-term evolution of patient interaction with the CONTROL-IQ (Tandem™) hybrid closed-loop (HCL) system in individuals with type 1 diabetes over 24 months. Specifically, the study examines user-initiated boluses and carbohydrate announcements to determine whether initially low-engagement users increase their involvement over time or, conversely, whether highly engaged users gradually rely more on automation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 453 (actual)
- First submitted
- 21 Feb 2025
- Start date
- 20 Mar 2025
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Centre Hospitalier Sud Francilien
- Diseases
- Type 1 diabetes
- NCT number
- NCT06858475
What you commit to
- Study type: Observational
- Participants enrolled: 453
- From 20 Mar 2025 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a type of diabetes other than type 1 diabetes.
Other
- Patients who have objected to the use of their data.
Who the study is looking for
- Patients using the CONTROL-IQ hybrid closed-loop system with data uploaded to the myDiabby platform at least once between October 2021 and October 2024, affiliated with the diabetology department of CHSF.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Sud Francilien Coordinator of this site? Confirm its status | Corbeil-Essonnes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.